Echelon Wealth Partners upgraded shares of Extendicare (TSE:EXE) from a hold rating to a buy rating in a research note released on Monday morning, Zacks.com reports.
A number of other research firms also recently issued reports on EXE. CIBC raised their price target on shares of Extendicare from C$8.25 to C$8.50 in a research report on Thursday, May 16th. TD Securities raised their price target on shares of Extendicare from C$8.00 to C$8.50 and gave the stock a hold rating in a research report on Thursday, May 16th. Finally, National Bank Financial raised their price target on shares of Extendicare from C$7.50 to C$8.50 and gave the stock a sector perform rating in a research report on Friday, May 17th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of C$8.90.
Extendicare stock opened at C$8.75 on Monday. The firm’s 50-day moving average is C$8.61 and its 200-day moving average is C$8.00. The company has a debt-to-equity ratio of 483.66, a quick ratio of 0.68 and a current ratio of 0.76. Extendicare has a 1 year low of C$5.95 and a 1 year high of C$9.02. The company has a market cap of $774.01 million and a P/E ratio of 29.56.
The company also recently disclosed a monthly dividend, which was paid on Thursday, August 15th. Investors of record on Thursday, August 15th were given a $0.04 dividend. The ex-dividend date of this dividend was Tuesday, July 30th. This represents a $0.48 annualized dividend and a yield of 5.49%. Extendicare’s dividend payout ratio is presently 162.16%.
Extendicare Company Profile
Extendicare Inc provides care and services for seniors in Canada. The company offers long term care services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management and consulting services to third-party owners.
Recommended Story: What is Compound Annual Growth Rate (CAGR)?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.